Oral Proteasome Inhibitor Marizomib and IMiD® Imunomodulatory Drug Pomalidomide Trigger Synergistic Anti-Myeloma Activity and Enhanced Proteasome Inhibition in Vitro and In Vivo

被引：0
|
作者：
Das, Deepika Sharma [1 ,2 ]
Ray, Arghya [1 ,2 ]
Song, Yan [1 ,2 ]
Richardson, Paul [1 ,2 ]
Trikha, Mohit [3 ]
Chauhan, Dharminder [1 ,2 ]
Anderson, Kenneth C. [1 ,4 ]
机构：
[1] Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, Boston, MA USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA
[3] Triphase Accelerator, San Diego, CA USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD® immunomodulatory drug pomalidomide
    Das, Deepika S.
    Ray, Arghya
    Song, Yan
    Richardson, Paul
    Trikha, Mohit
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (05) : 798 - 812
  • [2] Synergistic Anti-Myeloma Activity of a Proteasome Inhibitor Marizomib and IMiD® Immunomodulatory Drug Pomalidomide
    Das, Deepika Sharma
    Ravillah, Durgadevi
    Ray, Arghya
    Song, Yan
    Richardson, Paul G.
    Trikha, Mohit
    Chauhan, Dharminder
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [3] Effect of combination of proteasome inhibitor marizomib and immunomodulatory agent pomalidomide on synergistic cytotoxicity in multiple myeloma.
    Chauhan, Dharminder
    Das, Deepika Sharma
    Ray, Arghya
    Richardson, Paul G.
    Trikha, Mohit
    Anderson, Kenneth Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalan
    Sanchez, Eric
    Li, Mingjie
    Steinberg, Jeffrey A.
    Wang, Cathy
    Shen, Jing
    Bonavida, Benjamin
    Li, Zhi-Wei
    Chen, Haiming
    Berenson, James R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (04) : 569 - 581
  • [5] Molecular mechanisms mediating anti-myeloma activity of proteasome inhibitor PS-341.
    Hideshima, T
    Mitsiades, C
    Akiyama, M
    Hayashi, T
    Chauhan, D
    Richardson, PG
    Schlossman, RL
    Podar, K
    Munshi, NC
    Mitsiades, N
    Anderson, KC
    BLOOD, 2002, 100 (11) : 814A - 814A
  • [6] MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity
    Saha, Manujendra N.
    Jiang, Hua
    Jayakar, Jennifer
    Reece, Donna
    Branch, Donald R.
    Chang, Hong
    CANCER BIOLOGY & THERAPY, 2010, 9 (11) : 936 - 944
  • [7] Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma
    Chauhan, Dharminder
    Singh, Ajita V.
    Ciccarelli, Bryan
    Richardson, Paul G.
    Palladino, Michael A.
    Anderson, Kenneth C.
    BLOOD, 2010, 115 (04) : 834 - 845
  • [8] NATURAL POLYPHENOLS ANTAGONIZE THE ANTI-MYELOMA ACTIVITY OF PROTEASOME INHIBITOR BORTEZOMIB BY DIRECT CHEMICAL INTERACTION
    Kim, T.
    Park, J.
    Oh, B.
    Min, H. J.
    Jeong, T. -S.
    Lee, J. H.
    Suh, C.
    Cheong, J. -W.
    Kim, H. J.
    Yoon, S. -S.
    Park, S. B.
    Lee, D. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 417 - 417
  • [9] The oral proteasome inhibitor ONX 0912 has bone anabolic effects in addition to anti-myeloma effects
    Hurchla, Michelle A.
    Hornick, Mary C.
    Li, Aixiao
    Collins, Lynne
    Kirk, Christopher J.
    Piwnica-Worms, David
    Vij, Ravi
    Tomasson, Michael H.
    Weilbaecher, Katherine N.
    CANCER RESEARCH, 2011, 71
  • [10] Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo
    Edwards, Claire M.
    Lwin, Seint T.
    Fowler, Jessica A.
    Oyajobi, Babatunde O.
    Zhuang, Junling
    Bates, Andreia L.
    Mundy, Gregory R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 268 - 272
12345